Is Argireline FDA approved?

Argireline is not evaluated or approved by the FDA. It is discussed for research and educational purposes only, not as medical guidance.

Is SYN-AKE FDA approved?

SYN-AKE is not evaluated or approved by the FDA. It is discussed for research and educational purposes only, not as medical guidance.

How is Argireline administered in research settings?

In research settings, Argireline is typically administered via the topical route. PeptideBase does not provide dosing or administration instructions.

How is SYN-AKE administered in research settings?

In research settings, SYN-AKE is typically administered via the topical route. PeptideBase does not provide dosing or administration instructions.

Home›Research›Compare›Argireline vs SYN-AKE

Peptide Comparison

Argireline vs SYN-AKE

Q: What is the difference between Argireline and SYN-AKE?

Argireline: Inhibits SNARE complex formation in facial muscles; reduces acetylcholine release locally; relaxes expression lines without systemic effects SYN-AKE: Reversibly antagonizes nicotinic acetylcholine receptors (nAChR) at neuromuscular junctions in facial skin, reducing involuntary muscle microcontractions. Effect is topical, localized, and fully reversible.

Both are Skin & Cosmetic peptides.

Argireline

Acetyl Hexapeptide-3

Skin & JointNot EvaluatedResearch Only

Half-life: N/A (topical)

18 providers listed

Full Argireline profile →

SYN-AKE

Dipeptide Diaminobutyroyl Benzylamide Diacetate

Skin & JointNot EvaluatedResearch Only

No providers listed yet

Full SYN-AKE profile →

Bottom line

Argireline has published research citations on file; SYN-AKE does not yet — the main evidence gap between them.

Quick Verdict

Argireline

SYN-AKE

Which One Should You Choose?

Your goal	Better option
Has published research citations	Argireline
More provider options (18 vs 0)	Argireline

Research summary only — not medical advice. Consult a qualified provider before making any decisions.

Side-by-Side Comparison

Argireline

SYN-AKE

Mechanism Family

Skin & Cosmetic

Half-life

N/A (topical)

—

FDA Status

not evaluated

Admin Routes

topical

Availability

Research Only

Providers

18 listed

None listed

Avail. Notes

Cosmetic peptide (acetyl hexapeptide-3). Sold as cosmetic ingredient by Lipotec/Sederma. Not regulated as a drug by FDA. No NDA or IND. Cosmetic anti-wrinkle ingredient only.

—

Research Evidence

Argireline

RCT · 3 key studies · most recent 2026

SYN-AKE

No citations on file

Research Citations

Argireline

RCT2017 · Journal of Cosmetic Dermatology

The efficacy study of the combination of tripeptide-10-citrulline and acetyl hexapeptide-3: a prospective, ra…

RCT2013 · American Journal of Clinical Dermatology

The anti-wrinkle efficacy of argireline, a synthetic hexapeptide, in Chinese subjects: a randomized, placebo-…

In vitro2026 · Biomater Adv

DES-mediated self-assembled polypeptides: Synergistic neuromuscular signaling inhibition for anti-aging.

SYN-AKE

No citations on file.

About Argireline

Inhibits SNARE complex formation in facial muscles; reduces acetylcholine release locally; relaxes expression lines without systemic effects

Research Areas

SNARE complex (SNAP-25) competitive inhibition reducing expression line depthwrinkle reduction documented in controlled human trialstopical cosmetic application — not a systemic peptidesoftening of dynamic lines over 4–8 weeks at 5–10% concentration

About SYN-AKE

Reversibly antagonizes nicotinic acetylcholine receptors (nAChR) at neuromuscular junctions in facial skin, reducing involuntary muscle microcontractions. Effect is topical, localized, and fully reversible.

Research Areas

wrinkle reductionexpression line softeningmuscle relaxationanti-aging

Safety Profile

Information below reflects published research data only — not medical advice. Consult a qualified provider before use.

Argireline

No established clinical contraindications. This is an investigational compound with limited human data and has not been evaluated by the FDA for safety in this context. Consult a qualified clinician.

SYN-AKE

No established clinical contraindications. This is an investigational compound with limited human data and has not been evaluated by the FDA for safety in this context. Consult a qualified clinician.

Find Providers

Where to source these peptides

Providers offering

Argireline

18 listed

Browse directory →

Providers offering

SYN-AKE

Browse directory →

PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.

More Skin & Cosmetic Comparisons

Browse all peptides →

Educational research tools — not medical advice.